Prognostic impact of extracellular volume fraction derived from equilibrium contrast-enhanced CT in HCC patients receiving immune checkpoint inhibitors
Abstract This study aimed to investigate whether extracellular volume (ECV) fraction derived from equilibration contrast-enhanced computed tomography (CECT) affects prognosis in HCC patients receiving ICIs. This retrospective study ultimately included 211 HCC patients undergoing ICIs, of whom 60 wer...
Saved in:
| Main Authors: | Xiaona Fu, Yusheng Guo, Kailu Zhang, Zhixuan Cheng, Chanyuan Liu, Yi Ren, Lianwei Miao, Weiwei Liu, Shanshan Jiang, Chen Zhou, Yangbo Su, Lian Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-97677-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors: A Retrospective Analysis
by: Fu X, et al.
Published: (2025-05-01) -
Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC
by: Zhenyun Yang, et al.
Published: (2024-12-01) -
Construction of a macrophage-related prognostic signature and assessment of immune checkpoint inhibitor efficacy of HCC
by: Shouge Zang, et al.
Published: (2025-07-01) -
Extracellular volume fraction quantification by equilibrium contrast-enhanced CT via automated segmentation predicts survival outcomes in bladder cancer: a propensity score-matched study
by: Weiwei Liu, et al.
Published: (2025-12-01) -
Efficacy and safety of TACE-HAIC combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for the patients with BCLC-defined stage B-C HCC
by: Bowen Liu, et al.
Published: (2025-07-01)